NDC 65044-1207

Pollens - Trees, Bottle Brush Callistemon spp.

Bottle Brush Callistemon Spp.

Pollens - Trees, Bottle Brush Callistemon spp. is a Percutaneous; Subcutaneous Injection, Solution in the Non-standardized Allergenic category. It is labeled and distributed by Jubilant Hollisterstier Llc. The primary component is Melaleuca Citrina Pollen.

Product ID65044-1207_542aadd7-a419-42a2-a51d-25c08491a652
NDC65044-1207
Product TypeNon-standardized Allergenic
Proprietary NamePollens - Trees, Bottle Brush Callistemon spp.
Generic NameBottle Brush Callistemon Spp.
Dosage FormInjection, Solution
Route of AdministrationPERCUTANEOUS; SUBCUTANEOUS
Marketing Start Date1941-04-19
Marketing CategoryBLA / BLA
Application NumberBLA103888
Labeler NameJubilant HollisterStier LLC
Substance NameMELALEUCA CITRINA POLLEN
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 65044-1207-2

10 mL in 1 VIAL (65044-1207-2)
Marketing Start Date1941-04-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65044-1207-2 [65044120702]

Pollens - Trees, Bottle Brush Callistemon spp. INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103888
Product TypeNON-STANDARDIZED ALLERGENIC
Marketing Start Date1941-04-19

NDC 65044-1207-3 [65044120703]

Pollens - Trees, Bottle Brush Callistemon spp. INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103888
Product TypeNON-STANDARDIZED ALLERGENIC
Marketing Start Date1941-04-19

NDC 65044-1207-4 [65044120704]

Pollens - Trees, Bottle Brush Callistemon spp. INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103888
Product TypeNON-STANDARDIZED ALLERGENIC
Marketing Start Date1941-04-19

Drug Details

Active Ingredients

IngredientStrength
MELALEUCA CITRINA POLLEN.05 g/mL

Pharmacological Class

  • Non-Standardized Pollen Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Pollen [CS]
  • Allergens [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.